Having trouble viewing this email? View in your browser.
ESCMID Logo

23 March 2021
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 

ECCMID Late(breaker) abstract submission – prepare your abstract!

The latebreaker abstract submission for ECCMID 2021 will open from 26 April until 7 May 2021. 

Be sure to take this opportunity to submit your newly-emerging data and results.  The ECCMID Programme Committee will allow, as an exception this year, for the submission of regular research abstracts during the late-breaker call, for members of our community who could not prepare and submit their work during the regular call, due to involvement in the pandemic response. These abstracts could belong to any of the abstract categories, but abstracts focusing on COVID-19 and the other late-breaker categories are highly encouraged.   

Find out more on the ECCMID website. 

› Read more

New ESCMID online postgraduate courses now available for registration

The ESCMID online postgraduate courses: 

  • Implant associated infection: basic principles of diagnosis and treatment 
  • Translation of recent advances in diagnostic methods to clinical microbiology and infectious diseases
  • Paediatric infection management for the microbiologist, antimicrobial pharmacist and specialist in adult infectious diseases 

are now available for registration. 

Find the programme flyer and link for registration for these and many other ESCMID online courses on the ESCMID online courses website.

› Read more

ECCMID Community – Showcasing the creative side of ESCMID during pandemic times!

As a new part of the broader ECCMID programme, ESCMID is launching a call for submission of original photography documenting inspiring moments during pandemic times. We also welcome any other form of artwork, such as painting, pastels, poetry or prose!

Submitted original works will be included in a special gallery that will be available on the ECCMID online platform.

Find out more and submit your work on the ECCMID website.

› Read more
 

Updated ECCMID Preliminary Programme online!

A newly updated version of the ECCMID 2021 Preliminary Programme is now online!

Check the newly-added sessions and start planning your online learning journey now!

› Read more
 

World TB day – 24 March 2021

Tomorrow (Wednesday, 24 March 2021) marks world TB Day, a WHO initiative to raise public awareness about the devastating health, social and economic consequences of TB, and to step up efforts to end the global TB epidemic. The date marks the day in 1882 when Dr Robert Koch announced that he had discovered the bacterium that causes TB, which opened the way towards diagnosing and curing this disease.

ESCMID Professional Affairs Officer and Tuberculosis Expert, Prof. Emmanuelle Cambau, has written an article on the need for increased attention on infectious diseases such as TB, that continue to result in millions of preventable deaths. The article will be live on 24 March and can be accessed here.

ESCMID is also hosting an Online Postgraduate Education Course on tuberculosis and non-tuberculous mycobacterial infections from 15-17 April 2021, in conjunction with the Sociedad Chilena de Infectología (SOCHINF) and the Pontifica Universidad Cátólica de Chile School of Medicine. Find out more and sign up on the ESCMID Online Courses website.

› Read more
 

EMA communication: Latest updates on COVID-19 vaccines

We would like to bring to your attention the recent EMA communications on COVID-19 vaccines:

Please check EMA’s dedicated webpage on COVID-19 for the latest updates.

› Read more
 

GARDP Live Webinar: Discovering and developing new treatments for tuberculosis

Don’t miss the next GARDP webinar, which will take place tomorrow, 24 March 2021 from 14:30-16:00 CET. Join Nader Fotouhi from CSO TB Alliance (US) as he explores the development of new treatments for tuberculosis.

The session will be moderated by Lydia Nakiyingi, University College of Health Sciences (Uganda).

Register on the GARDP website.

› Read more
 

EMA communication: “Human Medicines Highlights” Newsletter – March 2021 issue

EMA is pleased to share with ESCMID the latest edition of the monthly EMA Newsletter which includes decisions by EMA Scientific Committees and updates on medicines safety.

You can access the Newsletter by clicking here. Previous editions can also be found on this page.

Please feel free to disseminate the EMA Newsletter to anyone else who might be interested in this information.

› Read more
 

CMI highlight: Interpreting Burkholderia pseudomallei disc diffusion susceptibility test results by the EUCAST method

In some parts of the tropics, melioidosis is an important public health problem and diagnostic laboratories frequently encounter Burkholderia pseudomallei. Most of these laboratories use disc diffusion for antimicrobial susceptibility testing but have had difficulty with B. pseudomallei because of a lack of internationally accepted criteria to interpret the results. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) has recently published guidelines for interpretation of disc diffusion testing for B. pseudomallei, which include the adoption of the new EUCAST interpretative categorisation of susceptibility and resistance. As a consequence, laboratories have been faced with reporting antimicrobial agents of proven effectiveness for melioidosis treatment as ‘I’ (Susceptible, increased exposure) instead of ‘S’ (Susceptible), creating confusion for clinicians. In this commentary authors briefly explain the background to these changes, affirm that the recommended antibiotics with appropriately high doses can be used against B. pseudomallei reported as ‘I’ by the EUCAST method, and suggest how laboratories should use the new criteria to inform clinical practice.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.